WallStreetZenWallStreetZen

NASDAQ: MRKR
Marker Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Marker Therapeutics earnings were -$12.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest MRKR earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$1.7M, down 14.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MRKR reported annual earnings of -$12.2M, with 13.3% growth.

MRKR earnings history

Current Revenue
$3.5M
Current Earnings
-$12.2M
Current Profit Margin
-343%

MRKR Return on Equity

Current Company
-80.9%
Current Industry
-11%
Current Market
29.2%
MRKR's Return on Equity (-80.9%)... subscribe to Premium to read more.
High Return on Equity Performance

MRKR Return on Assets

Current Company
-67%
Current Industry
-7.4%
MRKR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MRKR announces earnings.

MRKR Return on Capital Employed

Current Company
-72.51%
Current Industry
-1.8%
MRKR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRKR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MRKR-$12.18M-$12.16MN/A-$0.79
TVGN-$30.75M-$31.42MN/A-$9.50
LGVN-$21.48M-$22.70MN/A-$1.29
SKYE-$55.20M-$55.92MN/A-$1.41
NNVC-$7.70M-$8.32MN/A-$0.48
View Top Biotech Stocks

Marker Therapeutics Earnings Reports & History FAQ

What were Marker Therapeutics's earnings last quarter?

Marker Therapeutics (NASDAQ: MRKR) reported Q4 2025 earnings per share (EPS) of -$0.04, up 90.48% year over year. Total MRKR earnings for the quarter were -$1.70 million. In the same quarter last year, Marker Therapeutics's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.

Is Marker Therapeutics profitable or losing money?

As of the last Marker Therapeutics earnings report, Marker Therapeutics is currently losing money. Marker Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$12.16 million, a 13.35% increase year over year.

What was MRKR's earnings growth in the past year?

As of Marker Therapeutics's earnings date in Q1 2026, Marker Therapeutics's earnings has grown year over year. MRKR earnings in the past year totalled -$12.16 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.